BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8469219)

  • 1. Leukemic blasts with markers of four cell lineages in Down's syndrome ("megakaryoblastic leukemia").
    Slørdahl SH; Smeland EB; Holte H; Grønn M; Lie SO; Seip M
    Med Pediatr Oncol; 1993; 21(4):254-8. PubMed ID: 8469219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down's syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction.
    Kojima S; Matsuyama T; Sato T; Horibe K; Konishi S; Tsuchida M; Hayashi Y; Kigasawa H; Akiyama Y; Okamura J
    Blood; 1990 Dec; 76(11):2348-53. PubMed ID: 2147864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed phenotype of blasts in acute megakaryocytic leukaemia and transient abnormal myelopoiesis in Down's syndrome.
    Yumura-Yagi K; Hara J; Kurahashi H; Nishiura T; Kaneyama Y; Osugi Y; Sakata N; Inoue M; Tawa A; Okada S
    Br J Haematol; 1992 Aug; 81(4):520-5. PubMed ID: 1390239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C; Creutzig U; Reinhardt D
    Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient myeloproliferative disorder in Down's syndrome: three cases with megakaryocytic markers.
    Sartori PC; Darbyshire PJ
    Pediatr Hematol Oncol; 1991; 8(2):139-45. PubMed ID: 1830754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome.
    Zipursky A; Thorner P; De Harven E; Christensen H; Doyle J
    Leuk Res; 1994 Mar; 18(3):163-71. PubMed ID: 8139285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute megakaryoblastic leukemia associated with mosaic Down's syndrome.
    Simon JH; Tebbi CK; Freeman AI; Brecher ML; Green DM; Sandberg AA
    Cancer; 1987 Nov; 60(10):2515-20. PubMed ID: 2959356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia: in vitro drug sensitivity and outcome.
    Savaşan S; Buck S; Raimondi SC; Becton DL; Weinstein H; Chang M; Ravindranath Y
    Leuk Lymphoma; 2006 Oct; 47(10):2076-83. PubMed ID: 17071479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan myeloid antigen-negative pediatric acute megakaryoblastic leukemia.
    Cetin N; Lorsbach RB
    Pediatr Blood Cancer; 2014 Nov; 61(11):2089-91. PubMed ID: 24962432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysmegakaryopoiesis resembling acute megakaryoblastic leukemia in treated acute myeloid leukemia.
    Rosenthal NS; Farhi DC
    Am J Clin Pathol; 1991 Apr; 95(4):556-60. PubMed ID: 2014782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megakaryoblastic leukemia and Down's syndrome: a review.
    Zipursky A; Peeters M; Poon A
    Pediatr Hematol Oncol; 1987; 4(3):211-30. PubMed ID: 2978961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotype.
    Wang L; Peters JM; Fuda F; Li L; Karandikar NJ; Koduru P; Wang HY; Chen W
    Cytometry B Clin Cytom; 2015; 88(4):244-52. PubMed ID: 25361478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythroblastic and/or megakaryoblastic leukemia in Down syndrome: treatment with low-dose arabinosyl cytosine.
    Tchernia G; Lejeune F; Boccara JF; Denavit MF; Dommergues JP; Bernaudin F
    J Pediatr Hematol Oncol; 1996 Feb; 18(1):59-62. PubMed ID: 8556372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute megakaryoblastic leukemia in children and adolescents: a retrospective analysis of 24 cases.
    Ribeiro RC; Oliveira MS; Fairclough D; Hurwitz C; Mirro J; Behm FG; Head D; Silva ML; Raimondi SC; Crist WM
    Leuk Lymphoma; 1993 Jul; 10(4-5):299-306. PubMed ID: 8220128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down's syndrome and mixed acute leukemia in infants.
    Penchansky L; Kaplan SS; Stolc V; Krause JR
    Cancer; 1991 Jul; 68(2):414-7. PubMed ID: 1829979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target cell of leukemic transformation in acute megakaryoblastic leukemia.
    Koike T; Urushiyama M; Narita M; Saitoh H; Ishida F; Imashuku S; Morioka Y; Utsumi J; Ishizuka T; Tsuruta T
    Am J Hematol; 1990 Aug; 34(4):252-8. PubMed ID: 2164321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute megakaryoblastic leukemia in Down syndrome.
    Hitzler JK
    Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1066-9. PubMed ID: 17943965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute megakaryoblastic leukemia.
    Gassmann W; Löffler H
    Leuk Lymphoma; 1995; 18 Suppl 1():69-73. PubMed ID: 7496359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of erythroid-specific genes in megakaryoblastic disorders.
    Ito E; Kasai M; Toki T; Arai K; Yokoyama M
    Leuk Lymphoma; 1996 Nov; 23(5-6):545-50. PubMed ID: 9031085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute megakaryocytic leukemia in children. Clinical, immunologic, and cytogenetic findings in two patients.
    Slavc I; Urban C; Haas OA; Kroisel PM; Köller U
    Cancer; 1991 Nov; 68(10):2266-72. PubMed ID: 1833041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.